Erez Vigodman, the Chief Executive Officer of the Israeli generic drugmaker giant Teva Pharmaceutical Industries stepped down effective immediately on Monday, the company said.
Vigodman will be replaced on an interim basis by Yitzhak Peterburg, who has been chairman of Teva's board of directors, according to Reuters.
Read more